19 Jul 2021India
Government building buffer stock of COVID-19 drugs before third wave
The Indian government is currently working to build a buffer stock of coronavirus drugs as well as some other common drugs and supplements.
29 May 2021India
COVID-19: Centre to discontinue allocation of Remdesivir to states
The Indian government has decided to stop the central allocation of Remdesivir to states, citing sufficient supply of the antiviral drug being used to treat severe coronavirus patients.
28 May 2021Madhya Pradesh
Student duped victims of over Rs. 2L for Remdesivir, held
An 18-year-old college student was arrested from Madhya Pradesh for allegedly cheating people on the pretext of providing them Remdesivir injections, Delhi police said on Friday.
19 May 2021Government of India
Keep stocks ready for third wave, government tells pharmaceutical firms
The Indian government has told top pharmaceutical companies in the country to start preparing for a third wave of the coronavirus pandemic and stock up key drugs in a span of the next two-three months.
19 May 2021COVID-19
Remdesivir may be dropped from COVID-19 treatment, says Gangaram doctor
The use of Remdesivir may soon be dropped from the government guidelines concerning COVID-19 treatment in India, a top doctor based in Delhi has said.
07 May 2021Madhya Pradesh
MP: Crash landing of plane carrying Remdesivir to be probed
Aviation experts will conduct a probe into the crash-landing of a Madhya Pradesh government plane carrying a stock of anti-viral drug Remdesivir at Gwalior Airport following a technical snag, a senior official said on Friday.
29 Apr 2021Gujarat
Gujarat: 90 Remdesivir vials worth Rs. 5 lakh seized
Five persons were arrested on Wednesday in Gujarat with 90 Remdesivir injections worth Rs. 4.86 lakh which they were planning to sell in the black market, police officials said.
27 Apr 2021Bombay High Court
How are individuals procuring, selling Remdesivir? Bombay HC asks Centre
The Bombay High Court on Tuesday asked the federal government how private individuals were procuring and selling the crucial drug, Remdesivir.
27 Apr 2021India
Gilead announces steps to expand availability of Remdesivir in India
American biopharmaceutical company Gilead has announced several steps to expand the availability of Remdesivir, which is a key therapeutic medicine used in the treatment of COVID-19 patients, in India.
23 Apr 2021Union Health Ministry
Government issues updated clinical guidance for management of COVID-19 patients
The Union Health Ministry has issued an updated "Clinical Guidance for Management of Adult COVID-19 Patients" recommending emergency use authorization of Remdesivir for patients with moderate to severe diseases, requiring supplemental oxygen, within ten days of onset of symptoms.
22 Apr 2021India
Coronavirus: Centre to supply Remdesivir to 19 worst-hit states
As India witnesses a huge demand for the antiviral drug Remdesivir amid a sharp surge in COVID-19 cases, the central government has announced an interim allocation of the drug to 19 states and Union Territories until April 30.
21 Apr 2021Yogi Adityanath
Book those black-marketing medicines like Remdesivir under NSA: Adityanath
Uttar Pradesh Chief Minister Yogi Adityanath on Wednesday directed officials to conduct raids on those involved in black-marketing of medicines like Remdesivir and book offenders under the National Security Act (NSA).
19 Apr 2021Maharashtra
Maharashtra BJP accused of illegally procuring Remdesivir; here's what happened
Even as the COVID-19 outbreak gets progressively worse in Maharashtra, the state is witnessing a fresh controversy over the alleged illegal procurement of the anti-viral drug Remdesivir by the Bharatiya Janata Party (BJP).
19 Apr 2021Maharashtra
Not afraid of inquiry: Fadnavis on pharma firm-Remdesivir issue
BJP leader Devendra Fadnavis, who is being targeted by the ruling parties in Maharashtra for objecting to Mumbai police's grilling of a pharma company's top executive over alleged stocking of Remdesivir vials, on Sunday said he was not afraid of any inquiry against him as he has not done anything wrong.
09 Apr 2021Maharashtra
COVID-19 drug Remdesivir's price must not cross Rs. 1400: Tope
The Maharashtra government on Thursday decided to cap the price of Remdesivir between Rs. 1,100 and Rs. 1,400 per vial with Health Minister Rajesh Tope calling for slashing the MRP of the key COVID-19 drug.
17 Oct 2020World Health Organization
Remdesivir found ineffective; India to reassess coronavirus treatment protocol
The second worst-hit nation in coronavirus pandemic, India, that takes pride in the remarkable recovery rate, will reassess coronavirus treatment protocol after a large-scale trial conducted by World Health Organization (WHO) found that four commonly used re-purposed drugs had little impact in reducing mortality.
13 Aug 2020United States of America
Coronavirus: Zydus Cadila launches cheapest version of Remdesivir in India
In a major development, Zydus Cadila has launched the cheapest generic version of Remdesivir, the antiviral drug being used to treat COVID-19, in India.
25 Jul 2020United States of America
Study identifies 21 existing drugs that could treat COVID-19
A recent study identified 21 existing drugs that could be used to treat COVID-19. The drugs can notably stop the replication of SARS-CoV-2, the coronavirus that causes COVID-19, the study found.
25 Jun 2020Tamil Nadu
Coronavirus: 5 states to receive first batch of Hetero's COVIFOR
Five states across India will be the first to receive Hetero Healthcare's COVID-19 drug, COVIFOR, the first generic brand of the experimental drug remdesivir.
24 Jun 2020United States of America
These drugs are in use for COVID-19 treatment in India
India has opened up, but the pandemic is not slowing down.
13 Jun 2020World Health Organization
Health Ministry adds loss of smell, taste to COVID-19 symptoms
The Health Ministry has expanded the list of symptoms of COVID-19 to include the loss of smell and taste.
02 Jun 2020United States of America
Remdesivir reportedly approved for COVID-19 treatment in India
Remdesivir has been approved by India's top drug regulator for "restricted emergency use" on COVID-19-infected adults and children.
13 May 2020COVID-19
Noida-based Jubilant to make COVID-19 drug Remdesivir in India
Noida-based Jubilant Life Sciences has announced a licensing agreement with Gilead to make Remdesivir, a drug that has shown promise in treating COVID-19, in India.
05 May 2020Hindustan Times
India gears up to develop key COVID-19 drug: Details here
The US recently approved Remdesivir, a key antiviral drug from Gilead Sciences, for emergency use on COVID-19 patients.
30 Apr 2020Anthony Fauci
New COVID-19 drug has 'clear cut' positive effect: Dr. Fauci
The US government's top infectious disease expert, Dr. Anthony Fauci said that a new COVID-19 drug has proven to be quite a 'good news' in clinical trials.